Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-21

Clinical Trial Update: Pirfenidone Effect on the Recovery of Renal Function in Septic Acute Kidney Injury [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating pirfenidone for the recovery of renal function in patients with septic acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esbriet (pirfenidone)

Snippet

Sponsor: Hospital Civil de Guadalajara | Conditions: Acute Kidney Injury, Sepsis | Phase 4 | Status: UNKNOWN